A detailed history of Xtx Topco LTD transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 53,088 shares of BCLI stock, worth $57,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,088
Holding current value
$57,335
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.22 - $0.42 $11,679 - $22,296
53,088 New
53,088 $12,000
Q3 2023

Nov 13, 2023

BUY
$0.2 - $2.08 $4,900 - $50,962
24,501 New
24,501 $4,000
Q1 2023

May 12, 2023

BUY
$1.43 - $3.3 $17,484 - $40,349
12,227 New
12,227 $40,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $39.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.